State Representative David Harris (R-Arlington Heights) has authored House Bill 2508, better known as the Right to Try Act, to allow terminally ill patients access to experimental treatments. If the legislation becomes law, it would make Illinois a national leader by allowing patients who have exhausted all other treatment options the ability to utilize promising treatments that are still awaiting final FDA approval.
“Sadly, terminally ill patients often lose their struggle for life because they cannot wait several years for the FDA to approve a potentially life-saving treatment,” said Harris. “While testing new medical treatments is hugely important to ensuring their safety and effectiveness, it is reasonable to allow someone who has been diagnosed as terminally ill to use one of those treatments with the recommendation and supervision of their doctor."
The Right to Try Act provides that an eligible patient with a terminal illness who has considered all other treatment options approved by the FDA may acquire from a manufacturer an investigational drug, biological product, or device that has successfully completed Phase I of a clinical trial, but has not yet been approved for general use by the FDA. The Phase I classification means that preliminary clinical trials have shown the treatment to be promising.
on Wednesday, February 18, 2015
Watch video here: http://www.ilga.gov/house/audvid.asp
on Friday, February 13, 2015
|Rep. Harris (center) presents Alex Todd, Prospect Heights Library Executive Director, and his staff with a Certificate of Recognition for their work on "Polish Storytime."|
Representative David Harris presented a Certificate of Recognition from the Illinois House of Representatives to Prospect Heights Library Executive Director Alex Todd and his staff for their outstanding work in developing the "Polish Storytime" hour at the library.